Dan Blat
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- interferon and immune responses
Papers in
- Oncology 5
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Parkinson's Disease Mechanisms and Treatments 2
- Neurological Disorders and Treatments 2
- Co-authors
- Zelig Eshhar (3 shared papers)Zoya Alteber (2 shared papers)Tova Waks (2 shared papers)Ehud Zigmond (1 shared paper)Mati Fridkin (3 shared papers)Moussa B. H. Youdim (2 shared papers)Lev M. Weiner (2 shared papers)Yoram Reiter (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (1 paper)Cancer Immunology Research (1 paper)Molecular Therapy (1 paper)Immunology and Cell Biology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- IsraelGreeceUnited Kingdom
In The Last Decade
Dan Blat
11 papers receiving 510 citations
Peers
Comparison fields: 5 of 56
- Oncology 257
- Immunology 174
- Virology 9
- Radiology, Nuclear Medicine and Imaging 45
- Ophthalmology 15
Countries citing papers authored by Dan Blat
This map shows the geographic impact of Dan Blat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Blat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Blat more than expected).
Fields of papers citing papers by Dan Blat
This network shows the impact of papers produced by Dan Blat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Blat. The network helps show where Dan Blat may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Blat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 215 | |
| 2 | 2014 | 110 | |
| 3 | 2018 | 71 | |
| 4 | 2007 | 43 | |
| 5 | 2018 | 39 | |
| 6 | 2006 | 21 | |
| 7 | 2024 | 16 | |
| 8 | 2011 | 9 | |
| 9 | 2010 | 2 | |
| 10 | 2010 | 1 | |
| 11 | 2023 | 1 |
About Dan Blat
Dan Blat is a scholar working on Oncology, Neurology, Immunology, Physiology and Neurology, having authored 11 papers that have together received 528 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (3 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Neurological Disorders and Treatments (2 papers), Inflammatory Bowel Disease (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Oncology (257 citations), Immunology (174 citations), Virology (9 citations), Radiology, Nuclear Medicine and Imaging (45 citations) and Ophthalmology (15 citations). Dan Blat has collaborated with scholars based in Israel, Greece and United Kingdom. Frequent co-authors include Zelig Eshhar, Zoya Alteber, Tova Waks, Ehud Zigmond, Mati Fridkin, Moussa B. H. Youdim, Lev M. Weiner, Yoram Reiter, Hans J. Stauss and Fabrice Benchetrit. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Immunology Research, Molecular Therapy, Immunology and Cell Biology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.